Skip to main content
Vai all'homepage della Commissione europea (si apre in una nuova finestra)
italiano italiano
CORDIS - Risultati della ricerca dell’UE
CORDIS

Boosting the reduction of the environmental impact of pharmaceutical products throughout their entire life cycle.

CORDIS fornisce collegamenti ai risultati finali pubblici e alle pubblicazioni dei progetti ORIZZONTE.

I link ai risultati e alle pubblicazioni dei progetti del 7° PQ, così come i link ad alcuni tipi di risultati specifici come dataset e software, sono recuperati dinamicamente da .OpenAIRE .

Risultati finali

Report on the standardization landscape and applicable standards (si apre in una nuova finestra)

Report summarizing the relevant standardization landscape and appliable standards

Roadmap for adoption of PAT and Digital Twin Technologies (including regulatory compliance requirements) (si apre in una nuova finestra)

Report that will consist in a summary review of SoA of PAT and Digital Twin adoption in European Pharmaceutical industry; a SWOT analysis to feed into an Opportunities Roadmap that also takes account of the regulatory hurdles, as well as recommendations for a favorable/enabling regulatory framework, without compromising safety.

"Concept paper on ""compliance-by-design"" key-drivers and roadmap of the possible regulatory pathways or relevant regulatory frameworks for the required ""compliance-by-design"" strategies" (si apre in una nuova finestra)

Concept paper that reviews the latest developments in the scientific review, regulation, and marketing authorization procedures in the respective fields (related to the ETERNAL technological processes and developments) to inform a ‘compliant-by-design’ strategy in relation to the developments as part of the ETERNAL cocreation process.

Report on the contribution to standardization (si apre in una nuova finestra)

Report outlining the contribution the project has/will make to standards.

Research roadmap and inventory of tools for the integration of existing knowledge into pharma risk assessment (si apre in una nuova finestra)

Public report that documents a research roadmap for the integration of scientific and regulatory knowledge into pharmaceutical risk assessment for fate modelling, bioavailability assessment and receptor identification, for regulatory testing and assessment, and inventory of tools for the integration of existing knowledge into pharma risk assessment.

Pubblicazioni

Project Eternal Overview Presentation (si apre in una nuova finestra)

Autori: Ferrer Pérez, Pablo; Sebastia-Luna, Paz; Henderson, John
Pubblicato in: 2025
Editore: ZENODO
DOI: 10.5281/ZENODO.10688671

A New Collaboration to Establish Safe and Sustainable Pharmaceutical Lifecycles by Design (si apre in una nuova finestra)

Autori: Henderson, John; Peeling Robert
Pubblicato in: 2025
DOI: 10.5281/zenodo.10788903

Organic Solvent Nanofiltration in Pharmaceutical Applications (si apre in una nuova finestra)

Autori: Xiaoa, Hui; Feng, Yanyue; Goundry, William R.F.; Karlsson, Staffan
Pubblicato in: Organic Process Research and Development, 2024, ISSN 0000-0000
Editore: American Chemical Society
DOI: 10.1021/acs.oprd.3c00470

È in corso la ricerca di dati su OpenAIRE...

Si è verificato un errore durante la ricerca dei dati su OpenAIRE

Nessun risultato disponibile

Il mio fascicolo 0 0